Nigel Stallard
Medical and Pharmaceutical Statistics Research Unit
University of Reading
U.K
Name/email consistency: high
- Statistical evaluation of an acute dermal toxicity test using the dermal fixed dose procedure. Stallard, N., Whitehead, A., Indans, I. Hum. Exp. Toxicol (2004)
- Including a time-of-year effect in the analysis of a matched case-control study. Stallard, N., Tombs, L. Stat. Med (2004)
- A statistical evaluation of the fixed dose procedure. Stallard, N., Whitehead, A. Altern. Lab. Anim (2004)
- Sequential designs for phase III clinical trials incorporating treatment selection. Stallard, N., Todd, S. Stat. Med (2003)
- Decision-theoretic designs for phase II clinical trials allowing for competing studies. Stallard, N. Biometrics (2003)
- Statistical evaluation of the fixed concentration procedure for acute inhalation toxicity assessment. Stallard, N., Whitehead, A., Indans, I. Hum. Exp. Toxicol (2003)
- Statistical evaluation of the revised fixed-dose procedure. Stalla, N., Whitehead, A., Ridgway, P. Hum. Exp. Toxicol (2002)
- Stopping rules for phase II studies. Stallard, N., Whitehead, J., Todd, S., Whitehead, A. Br. J. Clin. Pharmacol (2001)
- Decision-theoretic designs for pre-phase II screening trials in oncology. Stallard, N., Thall, P.F. Biometrics (2001)
- Exact sequential tests for single samples of discrete responses using spending functions. Stallard, N., Todd, S. Stat. Med (2000)
- Decision theoretic designs for phase II clinical trials with multiple outcomes. Stallard, N., Thall, P.F., Whitehead, J. Biometrics (1999)
- Sample size determination for phase II clinical trials based on Bayesian decision theory. Stallard, N. Biometrics (1998)